title: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
authors: Department of Oncology, Helsinki University Central Hospital, Finland.
authors: H
authors: H
authors: Joensuu
authors: P J
authors: PJ
authors: Roberts
authors: M
authors: M
authors: Sarlomo-Rikala
authors: L C
authors: LC
authors: Andersson
authors: P
authors: P
authors: Tervahartiala
authors: D
authors: D
authors: Tuveson
authors: S
authors: S
authors: Silberman
authors: R
authors: R
authors: Capdeville
authors: S
authors: S
authors: Dimitrijevic
authors: B
authors: B
authors: Druker
authors: G D
authors: GD
authors: Demetri
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors*; D006801:Humans; D000068877:Imatinib Mesylate; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000627:therapeutic use*; D012509:Sarcoma / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017154:Stromal Cells; D014055:Tomography, Emission-Computed
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D019788:Fluorodeoxyglucose F18; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl